Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, The Netherlands.
Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, Centre of Mental Health, University of Würzburg, Margarete-Höppel-Platz1, 97080, Würzburg, Germany.
Neuropsychopharmacology. 2022 Jul;47(8):1503-1512. doi: 10.1038/s41386-022-01291-8. Epub 2022 Mar 8.
Motivations shape our behaviour: the promise of reward invigorates, while in the face of punishment, we hold back. Abnormalities of motivational processing are implicated in clinical disorders characterised by excessive habits and loss of top-down control, notably substance and behavioural addictions. Striatal and frontal dopamine have been hypothesised to play complementary roles in the respective generation and control of these motivational biases. However, while dopaminergic interventions have indeed been found to modulate motivational biases, these previous pharmacological studies used regionally non-selective pharmacological agents. Here, we tested the hypothesis that frontal dopamine controls the balance between Pavlovian, bias-driven automated responding and instrumentally learned action values. Specifically, we examined whether selective enhancement of cortical dopamine either (i) enables adaptive suppression of Pavlovian control when biases are maladaptive; or (ii) non-specifically modulates the degree of bias-driven automated responding. Healthy individuals (n = 35) received the catechol-o-methyltransferase (COMT) inhibitor tolcapone in a randomised, double-blind, placebo-controlled cross-over design, and completed a motivational Go NoGo task known to elicit motivational biases. In support of hypothesis (ii), tolcapone globally decreased motivational bias. Specifically, tolcapone improved performance on trials where the bias was unhelpful, but impaired performance in bias-congruent conditions. These results indicate a non-selective role for cortical dopamine in the regulation of motivational processes underpinning top-down control over automated behaviour. The findings have direct relevance to understanding neurobiological mechanisms underpinning addiction and obsessive-compulsive disorders, as well as highlighting a potential trans-diagnostic novel mechanism to address such symptoms.
奖励的承诺能激发活力,而面对惩罚时,我们则会退缩。动机处理的异常与以过度习惯和失去自上而下控制为特征的临床障碍有关,特别是物质和行为成瘾。纹状体和额叶多巴胺被假设在各自产生和控制这些动机偏差方面发挥互补作用。然而,尽管多巴胺能干预确实被发现可以调节动机偏差,但这些先前的药理学研究使用了区域非选择性的药理学制剂。在这里,我们检验了这样一个假设,即额叶多巴胺控制着条件作用驱动的自动反应和工具性学习的行动价值之间的平衡。具体来说,我们研究了选择性增强皮质多巴胺是否(i)能够在偏差不适应时自适应地抑制条件作用控制;或者(ii)非特异性地调节偏差驱动的自动反应的程度。健康个体(n=35)在随机、双盲、安慰剂对照的交叉设计中接受了儿茶酚-O-甲基转移酶(COMT)抑制剂托卡朋,并完成了一个已知会引起动机偏差的动机 Go/NoGo 任务。支持假设(ii),托卡朋全局降低了动机偏差。具体来说,托卡朋提高了在无帮助的偏差情况下的表现,但在偏差一致的情况下,表现则受到损害。这些结果表明,皮质多巴胺在自上而下控制自动行为的动机过程的调节中具有非选择性作用。这些发现与理解成瘾和强迫症障碍的神经生物学机制直接相关,并强调了一种潜在的跨诊断新机制来解决这些症状。